← Back to directory

Franco Locatelli

Researcher Next ID · RN-019423

Researcher · Medicine

Università Cattolica del Sacro Cuore

Milan, Japan

Not currently recruitingFunding unknown
Works count
2,197
Citation count
74,442
H-index
128
i10-index
953

Research interests

Medicine
Immunology and Microbiology
Acute Lymphoblastic Leukemia research
Hematopoietic Stem Cell Transplantation
Acute Myeloid Leukemia Research
CAR-T cell therapy research
Immune Cell Function and Interaction

Publications

  • Exagamglogene Autotemcel for Severe Sickle Cell Disease

    New England Journal of Medicine · 2024 · 10.1056/nejmoa2309676

  • GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

    New England Journal of Medicine · 2023 · 10.1056/nejmoa2210859

  • Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

    New England Journal of Medicine · 2021 · 10.1056/nejmoa2033122

  • Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

    New England Journal of Medicine · 2020 · 10.1056/nejmoa1911326

  • Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses

    Cell Stress · 2020 · 10.15698/cst2020.04.216

  • CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

    New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2031054

  • Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

    The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30370-2

  • Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications

    Cell Death and Differentiation · 2019 · 10.1038/s41418-019-0292-y

  • Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation

    Frontiers in Immunology · 2019 · 10.3389/fimmu.2019.01179

  • Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

    Journal of Clinical Oncology · 2016 · 10.1200/jco.2016.67.3301

  • International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

    Transplantation and Cellular Therapy · 2015 · https://doi.org/10.1016/j.bbmt.2015.09.001

  • Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

    Blood · 2015 · 10.1182/blood-2015-09-669937

  • Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

    Journal of Clinical Oncology · 2015 · 10.1200/jco.2015.62.8289

  • HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders

    Blood · 2014 · 10.1182/blood-2014-03-563817

  • Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

    Gut · 2011 · 10.1136/gut.2010.214841

  • Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    Blood · 2011 · 10.1182/blood-2011-03-338707

  • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

    Blood · 2010 · https://doi.org/10.1182/blood-2009-10-248146

  • Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

    Nature Genetics · 2010 · 10.1038/ng.641

  • Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

    The Lancet · 2008 · https://doi.org/10.1016/s0140-6736(08)60690-x

  • Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

    Blood · 2008 · 10.1182/blood-2008-06-164103

  • Cotransplantation of ex vivo–expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

    Blood · 2007 · 10.1182/blood-2007-04-087056

  • Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term In vitro Culture and Do Not Exhibit Telomere Maintenance Mechanisms

    Cancer Research · 2007 · 10.1158/0008-5472.can-06-4690

  • Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.

    PubMed · 2005

  • Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice

    Experimental Hematology · 2004 · 10.1016/j.exphem.2004.01.002

  • Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

    PubMed · 1997 · 10.1182/blood.v89.10.3534

Current projects

    No projects listed.